Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Stanford University
Memorial Sloan Kettering Cancer Center
Mayo Clinic
German CLL Study Group
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.